Investigating the effect of auriclotherapy on the level of stress, anxiety and depression after mastectomy in women with breast cancer

Investigating the effect of auriclotherapy on the level of stress, anxiety and depression after mastectomy in women with breast cancer

A controlled clinical trial with parallel groups, double-blind, randomized by random selection from the envelopes corresponding to the numbers of the test and control groups on 70 patients.

in Isfahan breast cancer clinic. the test group will be treated with auriclotherapy (Relax, Mr. Shoulder, Long 2, Anxiety, Shenman and Thalamic points) up to ten weekly sessions and then Vaccaria Seed It is placed on the corresponding points. Then, patients are advised to press the pads for one minute every hour, and at the end of the week, the points will be stimulated again and seeds will be placed again. In the control group, auriclotherapy is not performed and only Vaccaria Seed patch is placed on the desired points every week. After the intervention sessions, the questionnaires will be given to the patients in two groups again.

Iranian nationality Not suffering from infectious diseases and other neurological diseases At least two weeks have passed since the mastectomy Not using antidepressants Reproductive age Obtaining a score of at least 19 in the 21-question DASS questionnaire before the intervention, Absence of infection and apparent abnormality in the ear

subjects in the intervention group: breast cancer patients who undergo auriclotherapy up to ten sessions weekly, and after that, Vaccaria Seed is placed on the relevant points. subjects in the control group: the breast cancer patients who do not undergo auriclotherapy, but only Vaccaria Seed path is placed on the desired points every week. And it is not recommended to press the points.

stress, anxiety and depression

At this stage, the trained person provides the sealed envelopes in which intervention and control groups are registered as number one and number two, respectively and hidden , and they are randomly assigned to two intervention and control groups. They find that neither the patients were previously aware of their choice nor the researcher has any knowledge in this field.

The questionnaire will be distributed among the patients by another trained person and will be completed and delivered by the patients. The trained person will determine the score of the questionnaire. Then the people who have obtained a score of 19 and above from the three scales of stress, anxiety and depression of the DASS questionnaire and meet the inclusion criteria will be included in the study. At this stage, the trained person provides the sealed envelopes in which intervention and control groups are registered as number one and number two, respectively and hidden , and they are randomly assigned to two intervention and control groups. They find that neither the patients were previously aware of their choice nor the researcher has any knowledge in this field.

Part of the data, such as the information related to the main outcome, will be published in the articles resulting from this study and the final report.

The access period starts 6 months after the results are published

Secondary data will be available only to researchers working in academic and scientific institutions

Data will only be available for use in meta-analysis studies.

To receive the data, contact the responsible person in this study via email.

After sending the request from the academic person, the email will be checked and after confirming the purpose of accessing the data, the person responsible for the study will respond to the request as soon as possible.